GENEVA, June 26 -- CONTERA PHARMA A/S filed a patent application (EP2025/085493) for “OLIGONUCLEOTIDES TARGETING GAL3ST1”. With publication no. WO/2026/120080, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....